Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paleerath Peerapen

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2025
The inhibitory effects of proteins secreted from trigonelline-treated renal cells on calcium oxalate crystals in vitro: Implications for kidney stone preventionSunisa Yoodee, Paleerath Peerapen, Wanida Boonmark, et al.
Biochimica Et Biophysica Acta|March 16, 2016
Alterations of proteins in MDCK cells during acute potassium deficiencyPaleerath Peerapen, Nardtaya Ausakunpipat, Prangwalai Chanchaem, et al.
Current Research in Food Science|May 2, 2024
Resveratrol inhibits calcium oxalate crystal growth, reduces adhesion to renal cells and induces crystal internalization into the cells, but promotes crystal aggregationPaleerath Peerapen, Pattaranit Putpeerawit, Wanida Boonmark, et al.
Cellular and Molecular Life Sciences : CMLS|July 28, 2022
Roles of heat-shock protein 90 and its four domains (N, LR, M and C) in calcium oxalate stone-forming processesSunisa Yoodee, Paleerath Peerapen, Sirikanya Plumworasawat, et al.
Current Research in Food Science|February 9, 2026
Systematic evaluation and comparison of the <i>in vitro</i> inhibitory activities of dietary supplements against calcium oxalate crystal formation, growth and aggregation: Implications for kidney stone preventionPaleerath Peerapen, Pattaranit Putpeerawit, Wanida Boonmark, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 7, 2023
The inhibitory effects of epigallocatechin-3-gallate on calcium oxalate monohydrate crystal growth, aggregation and crystal-cell adhesionRattiyaporn Kanlaya, Rasiyakapat Kuljiratansiri, Paleerath Peerapen, et al.
Cellular & Molecular Biology Letters|June 10, 2026
Chlorogenic acid mitigates calcium oxalate monohydrate crystal-induced epithelial-to-mesenchymal transition in renal epithelial cells via suppression of HSP60 expression and p38 signalingPaleerath Peerapen, Somsakul Phuangkham, Wanida Boonmark, et al.
Urolithiasis|February 6, 2025
Integrated proteomics reveals enrichment of oxidative stress and inflammatory proteins in the urine and stone matrix of calcium oxalate stone formersSuttipong Suttapitugsakul, Supatcha Sassanarakkit, Paleerath Peerapen, et al.
Computational and Structural Biotechnology Journal|July 4, 2025
Anion exchange chromatographic fractionation of urinary proteins followed by tandem mass spectrometry identifies potential natural inhibitors of calcium oxalate stonePiyaporn Rattananinsruang, Paleerath Peerapen, Sasinun Detsangiamsak, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2024
Trigonelline prevents high-glucose-induced endothelial-to-mesenchymal transition, oxidative stress, mitochondrial dysfunction, and impaired angiogenic activity in human endothelial EA.hy926 cellsPaleerath Peerapen, Wanida Boonmark, Suwichaya Chantarasaka, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2025
The inhibitory effects of proteins secreted from trigonelline-treated renal cells on calcium oxalate crystals in vitro: Implications for kidney stone preventionSunisa Yoodee, Paleerath Peerapen, Wanida Boonmark, et al.
Biochimica Et Biophysica Acta|March 16, 2016
Alterations of proteins in MDCK cells during acute potassium deficiencyPaleerath Peerapen, Nardtaya Ausakunpipat, Prangwalai Chanchaem, et al.
Current Research in Food Science|May 2, 2024
Resveratrol inhibits calcium oxalate crystal growth, reduces adhesion to renal cells and induces crystal internalization into the cells, but promotes crystal aggregationPaleerath Peerapen, Pattaranit Putpeerawit, Wanida Boonmark, et al.
Cellular and Molecular Life Sciences : CMLS|July 28, 2022
Roles of heat-shock protein 90 and its four domains (N, LR, M and C) in calcium oxalate stone-forming processesSunisa Yoodee, Paleerath Peerapen, Sirikanya Plumworasawat, et al.
Current Research in Food Science|February 9, 2026
Systematic evaluation and comparison of the <i>in vitro</i> inhibitory activities of dietary supplements against calcium oxalate crystal formation, growth and aggregation: Implications for kidney stone preventionPaleerath Peerapen, Pattaranit Putpeerawit, Wanida Boonmark, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 7, 2023
The inhibitory effects of epigallocatechin-3-gallate on calcium oxalate monohydrate crystal growth, aggregation and crystal-cell adhesionRattiyaporn Kanlaya, Rasiyakapat Kuljiratansiri, Paleerath Peerapen, et al.
Cellular & Molecular Biology Letters|June 10, 2026
Chlorogenic acid mitigates calcium oxalate monohydrate crystal-induced epithelial-to-mesenchymal transition in renal epithelial cells via suppression of HSP60 expression and p38 signalingPaleerath Peerapen, Somsakul Phuangkham, Wanida Boonmark, et al.
Urolithiasis|February 6, 2025
Integrated proteomics reveals enrichment of oxidative stress and inflammatory proteins in the urine and stone matrix of calcium oxalate stone formersSuttipong Suttapitugsakul, Supatcha Sassanarakkit, Paleerath Peerapen, et al.
Computational and Structural Biotechnology Journal|July 4, 2025
Anion exchange chromatographic fractionation of urinary proteins followed by tandem mass spectrometry identifies potential natural inhibitors of calcium oxalate stonePiyaporn Rattananinsruang, Paleerath Peerapen, Sasinun Detsangiamsak, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2024
Trigonelline prevents high-glucose-induced endothelial-to-mesenchymal transition, oxidative stress, mitochondrial dysfunction, and impaired angiogenic activity in human endothelial EA.hy926 cellsPaleerath Peerapen, Wanida Boonmark, Suwichaya Chantarasaka, et al.
Pageof 7